Publications

Aceves, S; Collins, MH; Rothenberg, ME; Furuta, GT; Gonsalves, N; Abonia, JP; Almonte, S; Andrews, R; Arrington, A; Arva, N; et al. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Journal of Allergy and Clinical Immunology. 2020; 145:28-37.

Bird, JA; Leonard, S; Groetch, M; Assa'ad, A; Cianferoni, A; Clark, A; Crain, M; Fausnight, T; Fleischer, D; Green, T; et al. Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group Report. Journal of Allergy and Clinical Immunology-In Practice. 2020; 8:75-90.e17.

Bitton, A; Avlas, S; Reichman, H; Itan, M; Karo-Atar, D; Azouz, NP; Rozenberg, P; Diesendruck, Y; Nahary, L; Rothenberg, ME; et al. A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis. Science Immunology. 2020; 5:eaaw2938-eaaw2938.

Dang, AT; Chundi, PK; Mousa, NA; Beyer, AI; Chansakulporn, S; Venter, C; Mersha, TB; Assa'ad, AH. The effect of age, sex, race/ethnicity, health insurance, and food specific serum immunoglobulin E on outcomes of oral food challenges. World Allergy Organization Journal. 2020; 13:100100-100100.

Eapen, A; Assa'ad, A. Asthma. In: Gupta R, Ed. Pediatric Food Allergy A Clinical Guide. Chan, Switzerland: Springer; 2020.

Hirano, I; Dellon, ES; Hamilton, JD; Collins, MH; Peterson, K; Chehade, M; Schoepfer, AM; Safroneeva, E; Rothenberg, ME; Falk, GW; et al. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. Gastroenterology. 2020; 158:111-122.e10.

Kottyan, LC; Parameswaran, S; Weirauch, MT; Rothenberg, ME; Martin, LJ. The genetic etiology of eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2020; 145:9-15.

Lindsley, AW. “RE: Lin JL, et al. ‘Immunologic assessment and KMT2D mutation detection in Kabuki syndrome.’ Clin Genet. 2015;88(3):255-260”. Clinical Genetics: an international journal of genetics and molecular medicine. 2020; 97:538-539.

Pesek, RD; Rothenberg, ME. Eosinophilic gastrointestinal disease below the belt. Journal of Allergy and Clinical Immunology. 2020; 145:87-89.e1.

Pilarowski, GO; Cazares, T; Zhang, L; Benjamin, JS; Liu, K; Jagannathan, S; Mousa, N; Kasten, J; Barski, A; Lindsley, AW; et al. Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome. Journal of Allergy and Clinical Immunology. 2020; 145:982-992.

Rosenberg, CE; Daly, T; Hung, C; Hsueh, I; Lindsley, AW; Bodamer, O. Prenatal and perinatal history in Kabuki Syndrome. American Journal of Medical Genetics, Part A. 2020; 182:85-92.

Shoda, T; Wen, T; Caldwell, JM; Collins, MH; Besse, JA; Osswald, GA; Abonia, JP; Arva, NC; MDd, DA; Capocelli, KE; et al. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study. Journal of Allergy and Clinical Immunology. 2020; 145:255-269.

Vanoni, S; Zeng, C; Marella, S; Uddin, J; Wu, D; Arora, K; Ptaschinski, C; Que, J; Noah, T; Waggoner, L; et al. Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2020; 145:239-254.e2.

Yukawa, M; Jagannathan, S; Vallabh, S; Kartashov, AV; Chen, X; Weirauch, MT; Barski, A. AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation. The Journal of Experimental Medicine. 2020; 217.